Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Heparin Market: By Type: Low Molecular Weight Heparin, Ultra-Low Molecular Weight Heparin, Unfractionated Heparin; By Application; By Route of Administration; By End Use; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Heparin Market Outlook

The global heparin market was estimated at USD 6.24 billion in 2020. The heparin market is expected to expand at a CAGR of 2.3% in the forecast period of 2023-2028.

 

Global Heparin Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Heparin prevents blood clot formation within the blood vessels and is used to treat heart conditions and unstable angina. It is also used in post-surgery, dialysis, and transfusion of blood. Heparin is usually injected into the muscle or veins directly to break up clots and maintain smooth blood fluidity.

 

Global Heparin Market: Properties and Applications

The heparin market can be divided based on segments like types, applications, route of administration, and end-uses.

 

Global Heparin Market By Appication

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The heparin market can be divided based on its types as low molecular weight heparin, ultra-low molecular weight heparin, and unfractionated heparin. They all are further subdivided into intravenous and subcutaneous.

The heparin industry can be divided based on its application sectors as:

  • Venous Thromboembolism
  • Atrial Fibrillation
  • Renal Impairment
  • Coronary Artery Disease
  • Others

The heparin industry is classified based on its route of administration into:

  • Intravenous
  • Subcutaneous

The heparin industry can be bifurcated based on its end-use as outpatient and inpatient.

The EMR report looks into the regional heparin markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Heparin Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Heparin Market Analysis

It is expected that the increased incidences of venous thromboembolism and cardiovascular disorders will fuel the heparin market growth over the forecast period. Roughly 900,250 people in the United States are affected by deep vein thrombosis and pulmonary embolism every year, according to data published by the Center for Disease Control and Prevention (CDC) in 2018. This factor is projected in the coming years to boost the regional demand for heparin. The high demand for anticoagulants is also expected to boost the overall heparin industry. In addition, high spending on health care and patient awareness are some of the key factors expected to accelerate the heparin market growth over the forecast period.

 

Global Heparin Market: Competitive Landscape

The report presents a detailed analysis of the following key players in the global heparin market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • GlaxoSmithKline plc (GSK)
  • Pfizer Inc. [NYSE: PFE]
  • LeoPharma A/S
  • Sanofi
  • Dr. Reddy’s Laboratories Ltd.
  • Aspen Pharmacare Holdings Limited
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Others

The EMR report gives an in-depth insight into the heparin market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Application, Route of Administration, End Use, Region
Breakup by Type Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin, Unfractionated Heparin
Breakup by Application Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, Others
Breakup by Route of Administration Intravenous, Subcutaneous
Breakup by End Use Outpatient, Inpatient
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered GlaxoSmithKline plc (GSK) [GSK (LON)], Pfizer Inc. [PFE (NYSE)], LeoPharma A/S, Sanofi [SAN (EPA)], Dr. Reddy’s Laboratories Ltd. [DRREDDY (NSE)], Aspen Pharmacare Holdings Limited, B. Braun Melsungen AG, Fresenius Kabi AG, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Heparin Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Heparin Historical Market (2018-2022) 
    8.3    Global Heparin Market Forecast (2023-2028)
    8.4    Global Heparin Market by Type
        8.4.1    Low Molecular Weight Heparin
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    Intravenous
                8.4.1.4.2    Subcutaneous
        8.4.2    Ultra-Low Molecular Weight Heparin
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Intravenous
                8.4.2.4.2    Subcutaneous
        8.4.3    Unfractionated Heparin
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
            8.4.3.4    Breakup by Type
                8.4.3.4.1    Intravenous
                8.4.3.4.2    Subcutaneous
    8.5    Global Heparin Market by Application
        8.5.1    Venous Thromboembolism
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Atrial Fibrillation
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Renal Impairment
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Coronary Artery Disease
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2018-2022)
            8.5.4.3    Forecast Trend (2023-2028)
        8.5.5    Others
    8.6    Global Heparin Market by Route of Administration
        8.6.1    Intravenous
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Subcutaneous
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
    8.7    Global Heparin Market by End Use
        8.7.1    Outpatient
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2022)
            8.7.1.3    Forecast Trend (2023-2028)
        8.7.2    Inpatient
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2022)
            8.7.2.3    Forecast Trend (2023-2028)
    8.8    Global Heparin Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2018-2022)
        9.1.2    Forecast Trend (2023-2028)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2018-2022)
        9.2.2    Forecast Trend (2023-2028)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2018-2022)
        9.3.2    Forecast Trend (2023-2028)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2018-2022)
        9.4.2    Forecast Trend (2023-2028)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2018-2022)
        9.5.2    Forecast Trend (2023-2028)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    GlaxoSmithKline plc
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Pfizer Inc.
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    LeoPharma A/S
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Sanofi S.A
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Dr. Reddy’s Laboratories Ltd.
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Aspen Pharmacare Holdings Limited
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7   B. Braun Melsungen AG
            11.2.7.1    Company Overview
            11.2.7.2    Product Portfolio
            11.2.7.3    Demographic Reach and Achievements
            11.2.7.4    Certifications
        11.2.8   Fresenius Kabi AG
            11.2.8.1    Company Overview
            11.2.8.2    Product Portfolio
            11.2.8.3    Demographic Reach and Achievements
            11.2.8.4    Certifications
        11.2.9   Others 
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Heparin Market: Key Industry Highlights, 2018 and 2028
2.    Global Heparin Historical Market: Breakup by Type (USD Million), 2018-2022
3.    Global Heparin Market Forecast: Breakup by Type (USD Million), 2023-2028
4.    Global Heparin Historical Market: Breakup by Application (USD Million), 2018-2022
5.    Global Heparin Market Forecast: Breakup by Application (USD Million), 2023-2028
6.    Global Heparin Historical Market: Breakup by Route of Administration (USD Million), 2018-2022
7.    Global Heparin Market Forecast: Breakup by Route of Administration (USD Million), 2023-2028
8.    Global Heparin Historical Market: Breakup by End Use (USD Million), 2018-2022
9.    Global Heparin Market Forecast: Breakup by End Use (USD Million), 2023-2028
10.    Global Heparin Historical Market: Breakup by Region (USD Million), 2018-2022
11.    Global Heparin Market Forecast: Breakup by Region (USD Million), 2023-2028
12.    North America Heparin Historical Market: Breakup by Country (USD Million), 2018-2022
13.    North America Heparin Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Europe Heparin Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Europe Heparin Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Asia Pacific Heparin Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Asia Pacific Heparin Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Latin America Heparin Historical Market: Breakup by Country (USD Million), 2018-2022
19.    Latin America Heparin Market Forecast: Breakup by Country (USD Million), 2023-2028
20.    Middle East and Africa Heparin Historical Market: Breakup by Country (USD Million), 2018-2022
21.    Middle East and Africa Heparin Market Forecast: Breakup by Country (USD Million), 2023-2028
22.    Global Heparin Market Structure

Key Questions Answered in the Report

The global heparin market attained a value of nearly USD 6.24 billion in 2020.

The market is projected to grow at a CAGR of 2.3% between 2021 and 2026.

The major drivers of the industry include increased incidences of venous thromboembolism and cardiovascular disorders, high spending on health care and patient awareness.

The high demand for anticoagulants is expected to be a key trend guiding the growth of the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The types of the product include low molecular weight heparin, ultra-low molecular weight heparin, and unfractionated heparin.

Heparin finds applications in venous thromboembolism, atrial fibrillation, renal impairment, and coronary artery disease, amongst others.

Heparin can have different end-uses like intravenous and subcutaneous.

The end-uses can be divided into outpatient and inpatient.

The leading players in this market are GlaxoSmithKline plc (GSK) [GSK (LON)], Pfizer Inc. [PFE (NYSE)], LeoPharma A/S, Sanofi [SAN (EPA)], Dr. Reddy’s Laboratories Ltd. [DRREDDY (NSE)], Aspen Pharmacare Holdings Limited, B. Braun Melsungen AG, Fresenius Kabi AG, Others.

Analyst Review

The global heparin market attained a value of USD 6.24 billion in 2020, driven by the increased incidences of venous thromboembolism and cardiovascular disorders, high spending on health care and patient awareness. Aided by the high demand for anticoagulants, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 2.3%.

EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. The types of the product include low molecular weight heparin, ultra-low molecular weight heparin, and unfractionated heparin. By application, the industry can be divided into venous thromboembolism, atrial fibrillation, renal impairment, and coronary artery disease, amongst others. heparin can have different end-uses like intravenous and subcutaneous. The key players in the above industry include GlaxoSmithKline plc (GSK) [GSK (LON)], Pfizer Inc. [PFE (NYSE)], LeoPharma A/S, Sanofi [SAN (EPA)], Dr. Reddy’s Laboratories Ltd. [DRREDDY (NSE)], Aspen Pharmacare Holdings Limited, B. Braun Melsungen AG, Fresenius Kabi AG, Others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER